Patent details

Basic Information

Publication number:

EP2855528

PCT Application Number:

US2013043452

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP137291746

PCT Publication Number:

WO2013181452

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS OF TREATING CANCER USING PD-L1 AXIS BINDING ANTAGONISTS AND VEGF ANTAGONISTS

French Title of Invention:

PROCÉDÉS DE TRAITEMENT DU CANCER AU MOYEN D'ANTAGONISTES LIANT L'AXE PD-1 ET D'ANTAGONISTES DE VEGF

German Title of Invention:

VERFAHREN ZUR KREBSBEHANDLUNG MIT PD-L1-ACHSENBINDENDEN ANTAGONISTEN UND VEGF-ANTAGONISTEN

SPC Number:

Dates

Filing date:

30/05/2013

Grant date:

19/06/2019

EP Publication Date:

08/04/2015

PCT Publication Date:

05/12/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/06/2019

EP B1 Publication Date:

19/06/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

30/05/2020

Expiration date:

30/05/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/06/2019

 

 

Name:

F. Hoffmann-La Roche AG

Address:

Grenzacherstrasse 124, 4070 Basel, Switzerland (CH)

Inventor

1

Name:

MAECKER, Heather

Address:

United States (US)

2

Name:

IRVING, Bryan

Address:

United States (US)

Priority

Priority Number:

201261653861 P

Priority Date:

31/05/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/282; A61K 31/513; A61K 31/519; A61K 39/00; A61K 39/395; C07K 16/22; C07K 16/28;

Publication

European Patent Bulletin

Issue number:

201925

Publication date:

19/06/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages